December 12, 2013
Novartis AG has reached a tentative settlement of its patent infringement suit over Accord Healthcare Inc. USA's pursuit of government approval for a generic form of the drug Myfortic, which prevents patients from rejecting transplanted organs, according to a joint motion filed Thursday in D.C. federal court.
July 03, 2013
Novartis AG hit Accord Healthcare Inc. USA with a patent infringement lawsuit Wednesday in District of Columbia federal court, alleging that Accord's attempt to create a generic form of Myfortic, a medication that prevents the human body from rejecting an organ transplant, infringes its patents.